Related Experiment Video
Updated: Aug 9, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
Eosinophil cationic protein in the sera of patients with Mycoplasma pneumonia
R Yamashita1, H Kitahara, T Kanemitsu
1Department of Pediatrics, Kitasato Institute Hospital, Tokyo, Japan.
Abstract:
In 1985 we reported that eosinophilia was found in many children with Mycoplasma pneumonia. We measured the serum concentrations of eosinophil cationic protein (ECP) produced by eosinophils in 25 children with Mycoplasma pneumonia, 25 with asthma and 11 with no disease (normal controls). The mean concentrations (+/- SD) of serum ECP in children with Mycoplasma pneumonia, with asthma and the normal controls were 18.7 +/- 12.6, 23.7 +/- 12.2 and 6.5 +/- 1.4 micrograms/ml, respectively. When compared with those of normal controls, these higher serum concentrations of ECP in children with Mycoplasma pneumonia and asthma were statistically significant (P < 0.001). The data were directly correlated with the presence of eosinophilia (r = 0.349). There was no relationship between the amount of ECP and the age of children with Mycoplasma pneumonia. These results suggest that ECP may work as a factor causing a persistent cough similar to asthma in children with Mycoplasma pneumonia.
Insights
Children with Mycoplasma pneumonia and asthma exhibit elevated serum eosinophil cationic protein (ECP) levels, indicating eosinophil activation. These elevated ECP levels correlate with eosinophilia and may contribute to persistent cough in Mycoplasma pneumonia.
Area of Science:
- Pediatrics
- Immunology
- Respiratory Medicine
Background:
- Previous research in 1985 indicated eosinophilia in children with Mycoplasma pneumonia.
- Eosinophil cationic protein (ECP) is a marker of eosinophil activation and degranulation.
Purpose of the Study:
- To measure serum ECP concentrations in children with Mycoplasma pneumonia.
- To compare ECP levels in children with Mycoplasma pneumonia, asthma, and healthy controls.
- To investigate the correlation between ECP levels, eosinophilia, and persistent cough.
Main Methods:
- Serum ECP concentrations were measured in 25 children with Mycoplasma pneumonia, 25 with asthma, and 11 healthy controls.
- Statistical analysis was performed to compare ECP levels between groups and assess correlations.
Main Results:
- Mean serum ECP levels were significantly higher in children with Mycoplasma pneumonia (18.7 +/- 12.6 microg/ml) and asthma (23.7 +/- 12.2 microg/ml) compared to normal controls (6.5 +/- 1.4 microg/ml) (P < 0.001).
- Elevated ECP concentrations showed a direct correlation with the presence of eosinophilia (r = 0.349).
- No relationship was found between ECP levels and the age of children with Mycoplasma pneumonia.
Conclusions:
- Children with Mycoplasma pneumonia and asthma have significantly elevated serum ECP levels, suggesting eosinophil involvement.
- ECP may be a contributing factor to persistent cough in children with Mycoplasma pneumonia, similar to its role in asthma.
- ECP serves as a valuable biomarker for assessing eosinophil activation in pediatric respiratory conditions.
Related Concept Videos
Pneumonia III: Complications and Assessment
Atypical Pneumonia

